Carisoprodol
- Product NDC
- 52959-026
- 11-digit product format
- 529590026
- Labeler code
- 52959
- Product ID
- 52959-026_8baadcf8-d2c4-40c6-9fa0-485a0d699745
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carisoprodol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- H.J. Harkins Company, Inc.
- Application
- ANDA040124
- Marketing category
- ANDA
- Marketing start
- 1996-01-24
- Marketing end
- 0000-00-00
- Substance
- CARISOPRODOL
- Active strength
- 350 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 52959-026-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-12 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-15 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-20 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-21 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-24 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-25 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-28 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-32 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-40 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-42 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-45 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-52 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-56 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-80 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
| 52959-026-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f1-f424-e053-dadaa90a57ce | Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 1959 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52959-026-30 | Prazolamine | 30 in 1 BOTTLE | TABLET | 30 | 350 mg | 18 |
| 52959-026-00 | Carisoprodol | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | | 4 |
| 52959-026-03 | Carisoprodol | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | | 4 |
| 52959-026-06 | Carisoprodol | 06 in 1 BOTTLE, PLASTIC | TABLET | 06 | | 4 |
| 52959-026-10 | Carisoprodol | 10 in 1 BOTTLE, PLASTIC | TABLET | 10 | | 4 |
| 52959-026-12 | Carisoprodol | 12 in 1 BOTTLE, PLASTIC | TABLET | 12 | | 4 |
| 52959-026-14 | Carisoprodol | 14 in 1 BOTTLE, PLASTIC | TABLET | 14 | | 4 |
| 52959-026-15 | Carisoprodol | 15 in 1 BOTTLE, PLASTIC | TABLET | 15 | | 4 |
| 52959-026-20 | Carisoprodol | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | | 4 |
| 52959-026-21 | Carisoprodol | 21 in 1 BOTTLE, PLASTIC | TABLET | 21 | | 4 |
| 52959-026-24 | Carisoprodol | 24 in 1 BOTTLE, PLASTIC | TABLET | 24 | | 4 |
| 52959-026-25 | Carisoprodol | 25 in 1 BOTTLE, PLASTIC | TABLET | 25 | | 4 |
| 52959-026-28 | Carisoprodol | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | | 4 |
| 52959-026-30 | Carisoprodol | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 4 |
| 52959-026-32 | Carisoprodol | 32 in 1 BOTTLE, PLASTIC | TABLET | 32 | | 4 |
| 52959-026-40 | Carisoprodol | 40 in 1 BOTTLE, PLASTIC | TABLET | 40 | | 4 |
| 52959-026-42 | Carisoprodol | 42 in 1 BOTTLE, PLASTIC | TABLET | 42 | | 4 |
| 52959-026-45 | Carisoprodol | 45 in 1 BOTTLE, PLASTIC | TABLET | 45 | | 4 |
| 52959-026-50 | Carisoprodol | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | | 4 |
| 52959-026-52 | Carisoprodol | 52 in 1 BOTTLE, PLASTIC | TABLET | 52 | | 4 |
| 52959-026-56 | Carisoprodol | 56 in 1 BOTTLE, PLASTIC | TABLET | 56 | | 4 |
| 52959-026-60 | Carisoprodol | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | | 4 |
| 52959-026-80 | Carisoprodol | 80 in 1 BOTTLE, PLASTIC | TABLET | 80 | | 4 |
| 52959-026-90 | Carisoprodol | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| .GAMMA.-AMINOBUTYRIC ACID | ACTIVE INGREDIENT | 2ACZ6IPC6I | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| CARISOPRODOL | ACTIVE INGREDIENT | 21925K482H | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| .GAMMA.-AMINOBUTYRIC ACID | ACTIVE MOIETY | 2ACZ6IPC6I | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| CARISOPRODOL | ACTIVE MOIETY | 21925K482H | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | |
| CARISOPRODOL | ACTIVE INGREDIENT | 21925K482H | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| CARISOPRODOL | ACTIVE MOIETY | 21925K482H | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| METHYLCELLULOSE (100 CPS) | INACTIVE INGREDIENT | 4GFU244C4J | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52959-026 | PRAZOLAMINE (CARISOPRODOL, GABA) KIT [PHYSICIAN THERAPEUTICS LLC] | 18 | Legacy NDC | 20110812_99265e39-af23-43eb-a552-305f0a218fdf.zip |
| 52959-026 | CARISOPRODOL TABLET [H.J. HARKINS COMPANY, INC.] | 4 | Legacy NDC, 23 package rows | 20120919_037618dc-8aed-4a96-93a5-69971f2a3742.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 52959-026-00 | 52959002600 | 100 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-03 | 52959002603 | 120 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-06 | 52959002606 | 06 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-10 | 52959002610 | 10 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-12 | 52959002612 | 12 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-14 | 52959002614 | 14 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-15 | 52959002615 | 15 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-20 | 52959002620 | 20 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-21 | 52959002621 | 21 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-24 | 52959002624 | 24 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-25 | 52959002625 | 25 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-28 | 52959002628 | 28 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-30 | 52959002630 | 30 in 1 BOTTLE | Historical |
| 52959-026-32 | 52959002632 | 32 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-40 | 52959002640 | 40 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-42 | 52959002642 | 42 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-45 | 52959002645 | 45 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-50 | 52959002650 | 50 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-52 | 52959002652 | 52 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-56 | 52959002656 | 56 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-60 | 52959002660 | 60 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-80 | 52959002680 | 80 in 1 BOTTLE, PLASTIC | Historical |
| 52959-026-90 | 52959002690 | 90 in 1 BOTTLE, PLASTIC | Historical |